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Abstract
Background: Paracoccidioides brasiliensis is a dimorphic fungus that causes the most prevalent
systemic mycosis in Latin America. The response to heat shock is involved in pathogenesis, as this
pathogen switches from mycelium to yeast forms in a temperature dependent fashion that is
essential to establish infection. HSP90 is a molecular chaperone that helps in the folding and
stabilization of selected polypeptides. HSP90 family members have been shown to present
important roles in fungi, especially in the pathogenic species, as an immunodominant antigen and
also as a potential antifungal therapeutic target.
Results: In this work, we decided to further study the Pbhsp90 gene, its expression and role in cell
viability because it plays important roles in fungal physiology and pathogenesis. Thus, we have
sequenced a Pbhsp90 cDNA and shown that this gene is present on the genome as a single copy.
We have also confirmed its preferential expression in the yeast phase and its overexpression during
dimorphic transition and oxidative stress. Treatment of the yeast with the specific HSP90 inhibitors
geldanamycin and radicicol inhibited growth at 2 and 10 μM, respectively.
Conclusion: The data confirm that the Pbhsp90 gene encodes a morphologically regulated and
stress-responsive protein whose function is essential to cell viability of this pathogen. This work
also enforces the potential of HSP90 as a target for antifungal therapies, since the use of HSP90
inhibitors is lethal to the P. brasiliensis yeast cells in a dose-responsive manner.
Background
Most cells react to temperature elevations in a stereotypi-
cal manner termed heat shock response, which is con-
served from bacteria to mammals [1]. Upon heating, the
cell almost completely represses transcription and transla-
tion except for a set of so-called heat shock proteins
(HSPs), thus initiating its adaptation to the new environ-
ment. The induction of molecular chaperones is also seen
after non-thermal stresses such as those caused by oxida-
tive stress, low pH and treatment with cytotoxic drugs.
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activity of protein folding. However, unlike other molec-
ular chaperones, in vivo HSP90 is not necessary for de novo
protein synthesis; it assists only a small set of proteins,
which are usually dependent on ATP-dependent HSP90
binding to perform their functions correctly [2]. HSP90
client proteins include several tyrosine and serine/threo-
nine kinases, steroid receptors and transcription factors
[3]. The HSP90 protein consists of a highly conserved N-
terminal nucleotide-binding domain, a flexible charged
linker and a C-terminal domain that contains a -MEEVD
conserved motif responsible for binding to tetratricopep-
tide-repeat (TPR) proteins [4].
HSP90 family members have been shown to play impor-
tant roles in fungi. In the model yeast Saccharomyces cere-
visiae, inhibition of HSP90 by an anti-HSP90 ribozyme
promotes cell lysis, indicating some potential as an anti-
fungal therapeutic target [5]. The Candida albicans HSP90
has been shown to be an immunodominant antigen, both
in a mouse model of infection and in human patients [6].
Based on this finding, a novel therapeutic strategy has
been devised using a human recombinant antibody to
HSP90, which shows intrinsic antifungal activity and syn-
ergy with amphotericin B both in vitro and in vivo. This
antibody is in clinical trials with encouraging results
against systemic candidiasis [7]. HSP90 immunogenicity
has also been applied to a phage-displayed vaccine tested
in mice, which acquired resistance to systemic C. albicans
infection [8].
HSP90 proteins are targeted by several different pharma-
cologic agents; two of them, radicicol and geldanamycin,
inhibit the protein's ATPase activity with great specificity
and potency. Derivatives of these drugs and several novel
HSP90 inhibitors are now in clinical trials for cancer
chemotherapy [9]. However, cancer chemotherapy is not
the only use for these drugs, as they have become useful in
studies of HSP90 function. Inactivation of the Leishmania
donovani HSP90 with geldanamycin or radicicol mimics
the transmission from the vector to the mammalian host,
inducing the differentiation from the insect promastigote
stage towards the pathogenic mammalian amastigote
stage [10]. HSP90 also influences stage differentiation in
Toxoplasma gondii, which led to its proposition as a poten-
tial drug target [11].
Paracoccidioides brasiliensis, a dimorphic fungus, can be
found either as a filamentous soil saprobe or as yeast cells
infecting mammalian hosts. Both forms can be cultivated
in vitro in different incubating temperatures, around 22°C
for mycelium and 36°C for yeast. Mycelium cells can be
transformed into yeast by raising the incubation tempera-
ture to 36°C; and then reverted to mycelium by lowering
the temperature [12]. The fungus undergoes a similar
morphological switch in vivo: the infection starts by inha-
lation of conidia or mycelium fragments from the envi-
ronment, which then transform into yeast in the host's
lungs. Pathogenicity has been intimately associated with
this process, as strains unable to differentiate into the
yeast form are avirulent [13]. Adaptation to different tem-
peratures thus seems to be paramount to both fungal
physiology and pathogenicity, a fact that has long elicited
interest on heat shock response in such pathogens. Several
P. brasiliensis molecular chaperones have been studied,
such as MDJ1 [14], HSP60 [15], HSP70 genes [16-19] and
HSP100 genes [20,21]. A boost in the knowledge of these
genes came from high throughput transcriptome sequenc-
ing and expression analyses [22-24], which revealed
cDNA sequences and some expression data from 48
molecular chaperones [25].
This work describes the complete cDNA characterization
of the HSP90 gene from P. brasiliensis (Pbhsp90) and its
expression profile, including differential expression in
yeast phase, induction during mycelium to yeast transi-
tion and oxidative stress. Moreover, analysis of its role on
cell viability was investigated with pharmacological
inhibitors.
Results and Discussion
The Pbhsp90 cDNA was first isolated during the P. brasil-
iensis transcriptome sequencing [22,24]. In order to con-
firm the hsp90 transcript sequence, we chose a single clone
which clustered in the Pbhsp90 transcriptome contig and
fully sequenced it. The sequence shows a single open read-
ing frame (ORF) encoding a predicted polypeptide with
706 amino acid residues that aligned with several known
HSP90 proteins from organisms as diverse as fungi, plants
and mammals. A search for conserved domains using
NCBI rpsblast identified the Bergerat-fold N-terminal
ATPase domain [26] that is typical of all HSP90 proteins.
Nine out of ten residues involved in ATP/ADP and geldan-
amycin binding at the N-terminal domain (Leu-34, Asn-
37, Lys-44, Asp-79, Gly-83, Met-84, Asn-92, Phe-124 and
Thr-171) were identical in P. brasiliensis and S. cerevisiae,
the only difference being a change from a lysine to an
arginine at position 98 [27]. The predicted PbHSP90 pro-
tein also presents the C-terminal conserved -MEEVD
motif. A total of 400 out of the 706 amino acid residues
are conserved across Homo sapiens, S. cerevisiae and P. bra-
siliensis (figure 1).
All prokaryotes and some eukaryotes are known to have a
single cytoplasmic copy of the hsp90 gene, but some fungi
present two copies [28,29]. In the later organisms, the two
genes encode proteins which are structurally very similar
and functionally identical. The only significant difference
between the two genes is their transcriptional pattern; one
is constitutively expressed and mildly induced duringPage 2 of 9
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expression of an HSP90 gene from an organism that har-
bours a single copy, e.g. C. albicans, is somewhat like a
combination of both patterns, with constitutive expres-
sion and marked stress induction of the same gene [29].
The next step in characterizing the Pbhsp90 gene was to
evaluate the number of copies present in the genome.
Southern blotting analysis using the Pbhsp90 cDNA as a
probe has shown only one copy on the genome (Figure
2). In addition, searching the recently released genome
sequence drafts from isolates Pb01, Pb18 and Pb03 [30]
with the Pbhsp90 cDNA reveals a single copy of the gene.
ClustalW alignment of PbHSP90 and other HSP90 family proteinsFigure 1
ClustalW alignment of PbHSP90 and other HSP90 family proteins. The Pbhsp90 ORF was translated and aligned with 
Saccharomyces cerevisiae (Hsp82p, accession number [GenBank: NP_015084.1]) and Homo sapiens (HSP90β, accession number 
[GenBank: AAQ63401.1]) homologues using ClustalW. Shaded amino acid residues are involved in the binding of either ATP/
ADP or geldanamycin in S. cerevisiae [27]. The N-terminal MEEVD motif (bold) is the binding site for the TPR domain of co-
chaperones. A total of 400 out of the 706 amino acid residues are conserved across the three species.Page 3 of 9
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conserved introns and the predicted proteins are 98–99%
identical to the one we obtained in this work.
The Pbhsp90 gene expression was then assessed by north-
ern blotting under several different experimental condi-
tions including non-stressed mycelium and yeast cultures,
cells undergoing the first 24 hours of the mycelium-to-
yeast transition, and oxidative-stressed yeast cells (Figure
3). As previously shown by electronic subtraction, cDNA
microarray and real-time RT-PCR [22-24], expression of
the Pbhsp90 gene can be observed in both morphological
phases, but it is around 4.5 times stronger in the yeast
phase (Figure 3 – panel A). These results are in accordance
to what has been observed in another dimorphic fungus,
Penicillium marneffei, in which the HSP90 protein is 5.29
times more expressed in the yeast phase [31]. The myc-
elium mRNA is slightly shorter than the yeast one, proba-
bly due to differences in the 3'- and/or 5'-untranslated
regions (UTRs) as ESTs from mycelium and yeast formed
a single cluster which corresponds to only one transcript;
this has been described before for other fungal genes [32].
Pbhsp90 expression during the mycelium-to-yeast transi-
tion (Figure 3 – panel B) is already increased 30 minutes
after the temperature shift, reaches its peak – about 25-
fold relative induction – at one hour and slowly decreases
during the following hours, reflecting a morphological
transition thermo-dependent response [33], which is also
observed by EST analysis [34]. A very similar pattern of
induction has been shown for the chaperone-encoding
genes hsp60 [15], hsp70 [16,18] and hsp104 [23].
HSP90 is known to be essential for the function of several
signal transduction kinases in organisms as diverse as fruit
flies [35], baker's yeast [36] and mammalians [37],
including members of the MAPK and PKA families
involved in fungal morphogenesis [38]. These proteins, as
most in the cell after a temperature elevation of more than
10°C, are prone to denature under circumstances when
signalling must occur to coordinate the transition. The
very large increase on the Pbhsp90 mRNA levels may thus
be seen not only as result of heat shock, but also as adap-
tation in the transition.
Another set of northern blots examined Pbhsp90 gene
expression under some of the conditions previously
shown to induce other fungal homologues. Hydrogen
peroxide treatment promoted only a slight increase in
Pbhsp90 expression, of 2.45-fold after 30 minutes (Figure
3, panel C). The H2O2 concentration used (15 mM) is far
below the maximum tolerated by P. brasiliensis, which is
close to 75 mM [39], but is three times higher than the
LD90 for S. cerevisiae cells at 30 minutes [40]. Differently,
two other chaperones have been shown to be induced by
5 mM H2O2 in P. brasiliensis [14]. In contrast to the poor
induction provoked by peroxide on Pbhsp90, treatment
with superoxide-generating menadione at 1 mM (Figure 3
– panel C) strongly induced Pbhsp90 expression in yeast
cells. H2O2 and superoxide are among the major reactive
oxygen species (ROS) used by mammalian macrophages
in the defence against fungal infection [41]. C. albicans
cells lacking Cu/Zn superoxide dismutase (SOD), a super-
oxide detoxification enzyme, showed increased suscepti-
bility to macrophage attack and had attenuated virulence
in mice [42]. In a review of the transcriptome sequencing
project, Campos et al. [43] have found three catalases and
three SODs in P. brasiliensis -isolate Pb01. The fact that
superoxide radicals strongly induced Pbhsp90 correlates
nicely with recent data from our group showing that SOD
specific activity in the P. brasiliensis yeast cell is as strong
as in non-pathogenic S. cerevisiae (Dantas et al., personal
communication), while specific catalase activity is over
2000 times higher [39]. Therefore, it seems that the H2O2
detoxification by P. brasiliensis is so efficient that little cel-
lular damage requiring HSP90 occurs.
It is not possible to study Pbhsp90 function by classical
genetic approaches because knockouts of members of this
family are usually not viable [28]. Furthermore, genetic
manipulation is still not optimized on the multinucleated
and multi-budding P. brasiliensis making RNA interference
unfeasible as well. Those challenges have been circum-
vented by means of a "pharmacological knockout" with
the potent and specific HSP90 inhibitors radicicol and
geldanamycin. A broth microdilution test shows that both
radicicol and geldanamycin inhibit the growth of P. brasil-
iensis – Pb01 yeast cells in a manner similar to amphoter-
Southern blot analysis of gene copy numberFigur  2
Southern blot analysis of gene copy number. Samples 
of 15 μg total DNA were digested with combinations of the 
restriction endonucleases ApaI (A), NdeI (N) and SacII (S), 
separated by agarose gel electrophoresis, blotted onto 
charged nylon membrane and hybridized with radioactively 
labelled PbHSP90 cDNA. Bars show molecular weight 
marker.Page 4 of 9
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penetrate P. brasiliensis cells and bind their targets. More-
over, it confirms that HSP90 inhibition is lethal to the cell
in a dose-responsive manner and consequently that its
function is essential to fungal physiology. Results similar
to these have been found in other microorganisms such as
S. cerevisiae and Schizosaccharomyces pombe [5,44]. The use
of sub-lethal concentrations of these drugs can be fore-
seen as an excellent form of further investigating the
broad heat shock response in P. brasiliensis and in special
Pbhsp90.
Conclusion
The data show that Pbhsp90 is a highly expressed gene,
under complex regulation by morphological and oxida-
tive stress signals. This picture resembles previous obser-
vations of other molecular chaperones, stressing even
more the importance of heat adaptation in P. brasiliensis
dimorphism and survival in the harsh environment inside
the mammalian host. This work also enforces the poten-
tial of HSP90 as a target for novel antifungal therapies,
since the use of HSP90 inhibitors is lethal to the P. brasil-
iensis yeast cells in a dose-responsive manner. Geldanamy-
cin, radicicol and the other members of the ever-growing
list of HSP90 inhibitors could be engineered to achieve
higher selectiveness for the fungal protein. Taken together,
these results confirm that the Pbhsp90 gene encodes a
morphologically and stress-responsive protein whose
function is essential to cell viability of this pathogen.
Pbhsp90 expression profiles in mycelium and yeast cells, during differentiation and in the presence of oxidative agentsFigure 3
Pbhsp90 expression profiles in mycelium and yeast cells, during differentiation and in the presence of oxidative 
agents. Total RNA (15 μg) extracted from P. brasiliensis was separated by denaturing agarose gel electrophoresis, blotted onto 
charged nylon membranes and probed with radioactively labelled Pbhsp90 cDNA. Panel A – mycelium (M) and yeast (Y) cells. 
Panel B – Mycelium cells grown at 22°C and after incubation at 36°C for up to 24 h. The membrane shown on panel B was 
washed to higher stringency to resolve the strong hybridization signals better. Panel C – Yeast cells incubated with 15 mM 
hydrogen peroxide or 1 mM menadione, a superoxide-generating reagent. In each panel, the top image represents the specific 
hybridization signal and the ethidium bromide stained 16S rRNA band in the bottom image.Page 5 of 9
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Susceptibility of P. brasiliensis yeast cells to HSP90 inhibitors geldanamycin and radicicolFigure 4
Susceptibility of P. brasiliensis yeast cells to HSP90 inhibitors geldanamycin and radicicol. Inhibition of cell growth 
by HSP90 targeting drugs or the control amphotericin B was tested by a broth microdilution test adapted from the interna-
tional standard M27-A2. Curves show mean plus standard error of the absorbance at OD595 nm measured from quadruplicate 
experiments. *statistically significant when compared to control (p < 0.05).
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Strains and cultures
P. brasiliensis strain Pb01 (ATCC-MYA-826) was used
throughout this study. Cells were maintained on semi-
solid Fava-Netto medium, incubated at 37°C for yeast
cells and 22°C for mycelia.
cDNA sequencing and assembly
A single cDNA cloned in a Lambda ZAP phage vector
(Stratagene) was excised in vivo according to the supplier's
manual. The resulting plasmid was sequenced with vec-
tor-encoded T3 and T7 and internal primers in a Mega-
BACE® (GE Healthcare) automatic sequencer. Base-
calling, filtering and assembly were done as described
before [24]. The sequence was deposited in GenBank
(accession number [GenBank: AY928608]).
Southern blot
Total DNA was obtained by phenol:chloroform extraction
of mechanically disrupted frozen yeast cells. Samples of
15 μg of DNA were digested, with combinations of three
restriction endonucleases (ApaI, NdeI and SacII) known
not to have internal sites in the Pbhsp90 cDNA, and sepa-
rated by agarose gel electrophoresis. The gel was blotted
onto a charged nylon membrane by upward capillary
transfer. The cDNA probe was amplified by PCR using vec-
tor primers. A total of 25 ng of the purified product was
radioactively labelled with α-P32-dATP (GE Healthcare)
using the MegaPrime labelling kit (GE Healthcare). The
hybridized membrane was then washed as described for
the northern blots below sequentially until low back-
ground was detected and then exposed to a phosphorim-
ager, which was scanned on a Typhoon® 9210 scanner (GE
Healthcare).
Northern blot
RNAs from mycelium-to-yeast transition and of isolated
mycelium and yeast cells were obtained as previously
described [45,46]. For the oxidative stress experiments,
yeast cells were washed and ressuspended in medium con-
taining either 15 mM H2O2 or 1 mM menadione. Samples
were then collected by centrifugation, frozen with liquid
nitrogen and disrupted. Total RNA was then obtained by
extraction with Trizol® reagent (Invitrogen). Fifteen micro-
gram samples of total RNA were separated by electro-
phoresis on formaldehyde-containing 1% agarose gels;
blotted onto charged nylon Hybond® N+ membranes (GE
Healthcare) and hybridized as described for the Southern-
blot. Hybridized membranes were then washed sequen-
tially with solutions containing SDS 0.1% and different
concentrations of SSPE in 20 minute rounds: 2× SSPE
50°C, 1× SSPE 50°C, 1× SSPE 65°C and 0,1× SSPE 65°C.
Each membrane was monitored with a Geiger counter
after each wash and exposed in a phosphorimager when
the background radioactivity was low enough. Resulting
bands were quantified using ImageQuant® software and
normalized by dividing the hybridization signal intensity
by the ethidium bromide stained 18S ribosomal RNA
band intensity.
Drug susceptibility testing
Drug susceptibility tests were adapted from the interna-
tional standard M27-A2 [47]. Yeast cells were grown on
RPMI defined medium and diluted to a 2× suspension
containing 105 cells/mL. Amphotericin B and geldanamy-
cin were diluted in dimethyl-sulfoxide (DMSO) to 100×
stock solutions; radicicol was diluted in ethanol. Working
solutions (2×) were then made with RPMI medium. A 100
μL aliquot of the 2× cell suspension was added to 100 μL
of the 2× drug solutions in U-shaped 96-well plates, so
that the final suspension reached a cell density of 105
cells/mL and 1% DMSO or ethanol. The plate was incu-
bated at 37°C for 7–10 days, when the minimal inhibi-
tory concentration (MIC) was directly observed. In order
to convey more precisely the observed difference in
growth, OD595 nm was measured with a GeneQuant® spec-
trophotometer. Each concentration was tested in quadru-
plicate experiments. Statistical analyses were done with
one-way analysis of variance (ANOVA) and the Tamhane
T2 multiple comparison test from SPSS 11.0 software.
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